marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Atara Biotherapeutics Balance Sheet 2011-2024 | ATRA
Annual Balance Sheet Atara Biotherapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
31.1 M | -22.1 M | -78 M | - | -58.6 M | -60.7 M | -79.2 M | -48 M | -23.7 M | -21.9 M | -51.6 M | -4.21 M | - |
Long Term Debt |
45.7 M | 58.1 M | 25.5 M | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
11.3 M | 12.8 M | 2.58 M | 1.73 M | 1.31 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 15.4 M | 13 M | 12.3 M | 503 K | 166 K | 216 K | 61.3 M | 6.72 M | - |
Total Current Liabilities |
142 M | 78.9 M | 106 M | 82.9 M | 36.7 M | 40 M | 27.6 M | 9.68 M | 9.71 M | 2.72 M | - | - | - |
Total Liabilities |
265 M | 250 M | 189 M | 126 M | 52.2 M | 53 M | 39.9 M | 10.2 M | 9.88 M | 2.94 M | 62.8 M | 8.02 M | - |
Deferred Revenue |
77.8 M | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-1.97 B | -1.69 B | -1.46 B | -1.12 B | -818 M | -527 M | -297 M | -177 M | -98.1 M | -40.9 M | -12.9 M | -4.11 M | - |
Total Assets |
166 M | 376 M | 468 M | 588 M | 343 M | 392 M | 218 M | 264 M | 325 M | 106 M | 51.8 M | 4.29 M | - |
Cash and Cash Equivalents |
25.8 M | 92.9 M | 106 M | 202 M | 74.3 M | 60.7 M | 79.2 M | 48 M | 23.7 M | 21.9 M | 51.6 M | 4.21 M | - |
Book Value |
-99.2 M | 127 M | 280 M | 462 M | 291 M | 339 M | 178 M | 254 M | 315 M | 103 M | -11 M | -3.73 M | - |
Total Shareholders Equity |
-99.2 M | 127 M | 280 M | 462 M | 291 M | 339 M | 178 M | 254 M | 315 M | 103 M | -11 M | -3.73 M | - |
All numbers in USD currency
Quarterly Balance Sheet Atara Biotherapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
35.2 M | 38.7 M | 42.2 M | 45.7 M | 48.5 M | 51.8 M | 54.9 M | 58.1 M | 3.76 M | 3.97 M | 17.5 M | 25.5 M | 24.6 M | 12.2 M | 12.6 M | 149 K | 13 M | 13 M | 13 M | 244 K | 85 K | 141 K | 196 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 13 M | 12.9 M | 13 M | 12.9 M | 12.3 M | 12.3 M | 12.3 M | 12.3 M | 503 K | 503 K | 503 K | 503 K | 166 K | 166 K | 166 K | 166 K | 216 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
233 M | 228 M | 264 M | 265 M | 240 M | 239 M | 237 M | 250 M | 181 M | 179 M | 173 M | 189 M | 140 M | 125 M | 131 M | 126 M | 126 M | 126 M | 126 M | 52.2 M | 52.2 M | 52.2 M | 52.2 M | 53 M | 53 M | 53 M | 53 M | 39.9 M | 39.9 M | 39.9 M | 39.9 M | 10.2 M | 10.2 M | 10.2 M | 10.2 M | 9.88 M | 9.88 M | 9.88 M | 9.88 M | 2.94 M | 2.94 M | 2.94 M | 2.94 M | 1.75 M | 1.75 M | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | 31.2 M | 41 M | 35.5 M | 33.5 M | - | 33.5 M | 33.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-2.04 B | -2.02 B | -2 B | -1.97 B | -1.91 B | -1.84 B | -1.77 B | -1.69 B | -1.62 B | -1.53 B | -1.55 B | -1.46 B | -1.37 B | -1.29 B | -1.2 B | -1.12 B | -1.12 B | -1.12 B | -1.12 B | -818 M | -818 M | -818 M | -818 M | -527 M | -527 M | -527 M | -527 M | -297 M | -297 M | -297 M | -297 M | -177 M | -177 M | -177 M | -177 M | -98.1 M | -98.1 M | -98.1 M | -98.1 M | -40.9 M | -40.9 M | -40.9 M | -40.9 M | -12.9 M | -12.9 M | - | - | - | - | - | - | - | - | - | - |
Total Assets |
143 M | 117 M | 165 M | 166 M | 189 M | 246 M | 302 M | 376 M | 368 M | 436 M | 397 M | 468 M | 450 M | 457 M | 530 M | 588 M | 588 M | 588 M | 588 M | 343 M | 343 M | 343 M | 343 M | 392 M | 392 M | 392 M | 392 M | 218 M | 218 M | 218 M | 218 M | 264 M | 264 M | 264 M | 264 M | 325 M | 325 M | 325 M | 325 M | 106 M | 106 M | 106 M | 106 M | 51.8 M | 51.8 M | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
46.5 M | 31.3 M | 35.1 M | 25.8 M | 64.9 M | 46 M | 48.9 M | 92.9 M | 66.5 M | 72 M | 103 M | 106 M | 115 M | 125 M | 151 M | 202 M | 200 M | 200 M | 200 M | 74.3 M | 74.3 M | 74.3 M | 74.3 M | 60.7 M | 60.7 M | 60.7 M | 60.7 M | 79.2 M | 79.2 M | 79.2 M | 79.2 M | 48 M | 48 M | 48 M | 48 M | 23.7 M | 23.7 M | 23.7 M | 23.7 M | 21.9 M | 21.9 M | 21.9 M | 21.9 M | 51.6 M | 51.6 M | - | - | 4.21 M | - | - | - | - | - | - | - |
Book Value |
-90.5 M | -111 M | -98.3 M | -99.2 M | -50.8 M | 7.45 M | 65 M | 127 M | 187 M | 257 M | 224 M | 280 M | 310 M | 332 M | 399 M | 462 M | 462 M | 462 M | 462 M | 291 M | 291 M | 291 M | 291 M | 339 M | 339 M | 339 M | 339 M | 178 M | 178 M | 178 M | 178 M | 254 M | 254 M | 254 M | 254 M | 315 M | 315 M | 315 M | 315 M | 103 M | 103 M | 103 M | 103 M | 50.1 M | 50.1 M | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
-90.5 M | -111 M | -98.3 M | -99.2 M | -50.8 M | 7.45 M | 65 M | 127 M | 187 M | 257 M | 224 M | 280 M | 310 M | 332 M | 399 M | 462 M | 462 M | 462 M | 462 M | 291 M | 291 M | 291 M | 291 M | 339 M | 339 M | 339 M | 339 M | 178 M | 178 M | 178 M | 178 M | 254 M | 254 M | 254 M | 254 M | 315 M | 315 M | 315 M | 315 M | 103 M | 103 M | 103 M | 103 M | -11 M | -11 M | - | - | -3.73 M | - | - | - | - | - | - | - |
All numbers in USD currency